Investigators
Study information
- Research Area: Cancer
- Research type: Hospital-based epidemiological retrospective study and a subsequent case-control experimental study
- Start date: Feb 01, 2019
- End date: Dec 12, 2020
Study aim of the objectives
The study aims to identify breast cancer genetic mutations and characterize ER, PR receptor status, and HER2 overexpression in Rwandan breast cancer patients.
Study setting/Area (Location)
CHUK, RMH, CHUB, KFH, Butaro hospital
Implementing institution
Rwanda Biomedical Center
Department/Division
Medical Research Centre